Dawn of a new era in molecular cancer therapeutics

Prog Drug Res. 2005;63:1-17. doi: 10.1007/3-7643-7414-4_1.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Drug Design*
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Patient Selection

Substances

  • Antineoplastic Agents